Suppr超能文献

在人骨桥蛋白N端凝血酶片段的一个38个氨基酸的结构域内鉴定双α4β1整合素结合位点。

Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.

作者信息

Bayless K J, Davis G E

机构信息

Department of Pathology and Laboratory Medicine, Texas A&M University Health Science Center, College Station, Texas 77843, USA.

出版信息

J Biol Chem. 2001 Apr 20;276(16):13483-9. doi: 10.1074/jbc.M011392200. Epub 2001 Jan 25.

Abstract

Previous work from our laboratory demonstrates that the alpha(4)beta(1) integrin is an adhesion receptor for OPN and that alpha(4)beta(1) binding site(s) are present in the N-terminal thrombin fragment of osteopontin (OPN) (Bayless, K. J., Meininger, G. A., Scholtz, J. M., and Davis, G. E. (1998) J. Cell Sci. 111, 1165-1174). The work presented here identifies two alpha(4)beta(1) binding sites within a recombinantly produced N-terminal thrombin fragment of human OPN. Initial experiments, using wild-type OPN containing an RGD sequence or an OPN-RGE mutant, showed identical alpha(4)beta(1)-dependent cell adhesive activity. A strategy to localize alpha(4)beta(1) binding sites within the thrombin fragment of osteopontin involved performing a series of truncation analyses. Removal of the last 39 amino acids (130) completely eliminated adhesion, indicating all binding activity was present within that portion of the molecule. Combined mutation and deletion analyses of this region revealed the involvement of dual alpha(4)beta(1) binding sites. Synthetic peptides for both regions in OPN, ELVTDFPTDLPAT (131) and SVVYGLR (162), were found to block alpha(4)beta(1)-dependent adhesion. The first peptide when coupled to Sepharose bound the alpha(4)beta(1) integrin directly whereas a mutated ELVTEFPTELPAT peptide showed a dramatically reduced ability to bind. These data collectively demonstrate that dual alpha(4)beta(1) integrin binding sites are present in a 38 amino acid domain within the N-terminal thrombin fragment of OPN.

摘要

我们实验室之前的研究表明,α(4)β(1)整合素是骨桥蛋白(OPN)的黏附受体,并且α(4)β(1)结合位点存在于骨桥蛋白(OPN)的N端凝血酶片段中(贝利斯,K. J.,迈宁格,G. A.,肖尔茨,J. M.,和戴维斯,G. E.(1998年)《细胞科学杂志》111卷,1165 - 1174页)。本文介绍的研究确定了在重组产生的人OPN的N端凝血酶片段内有两个α(4)β(1)结合位点。最初使用含有RGD序列的野生型OPN或OPN - RGE突变体进行的实验显示,二者具有相同的α(4)β(1)依赖性细胞黏附活性。在骨桥蛋白的凝血酶片段内定位α(4)β(1)结合位点的策略包括进行一系列截短分析。去除最后39个氨基酸(130)完全消除了黏附,表明所有结合活性都存在于该分子的这一部分内。对该区域进行的联合突变和缺失分析揭示了双重α(4)β(1)结合位点的参与。发现OPN中这两个区域的合成肽ELVTDFPTDLPAT(131)和SVVYGLR(162)可阻断α(4)β(1)依赖性黏附。第一种肽与琼脂糖偶联后可直接结合α(4)β(1)整合素,而突变后的ELVTEFPTELPAT肽的结合能力则显著降低。这些数据共同表明,双重α(4)β(1)整合素结合位点存在于OPN的N端凝血酶片段内的一个38个氨基酸的结构域中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验